Abstract 3465: Context-dependent effects of ATRX loss on telomere biology in glioma cells

Jacqueline A. Brosnan‐Cashman(Johns Hopkins University), Alan K. Meeker(Johns Hopkins University), David Esopi(AstraZeneca (United States)), Dinesh Rakheja(Southwestern Medical Center), Kaylar M. Myers(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Christopher M. Heaphy(Boston University), Walter T. Barry(Johns Hopkins University), Anthony Rizzo(Johns Hopkins University), Christine Davis(Johns Hopkins University), Ming Yuan(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cancer Research
July 1, 2017
10.1158/1538-7445.am2017-3465
Cited by 0

Related Papers

<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711